Cardiovascular Systems
Cardiovascular Systems, Inc. is a medical technology company that specializes in developing and commercializing innovative solutions for treating peripheral and coronary vascular diseases. The company focuses on providing physicians with advanced tools to address complex conditions, particularly those involving calcified plaque, which poses significant challenges in managing peripheral artery disease (PAD) and coronary artery disease (CAD). Cardiovascular Systems offers catheter-based platforms, including its orbital atherectomy systems, designed to treat plaque in leg arteries above and below the knee. The Diamondback 360 and Stealth 360 systems are among its notable products, with sales of the peripheral orbital atherectomy systems contributing the majority of the company’s revenue, primarily generated in the United States.
CarePICS is a software application development company focused on enhancing healthcare services through technology. It specializes in an online platform that facilitates consultations between patients and healthcare professionals, particularly for those suffering from peripheral artery disease. The platform allows podiatrists, skilled nursing facilities, home health agencies, and primary care physicians to capture patient information, including wound images and measurements. By removing barriers to care, CarePICS empowers patients to manage their health effectively while consulting with doctors remotely, thereby improving clinical outcomes and overall patient care.
Leviticus Cardio Ltd is a company based in Petach Tikva, Israel, specializing in the development of a wireless coplanar energy transfer system aimed at improving the quality of life for patients with congestive heart failure. Founded in 2008, the company has created the Fully Implanted Ventricular Assist Device (FIVAD), a wireless heart pump system designed to power implanted mechanical circulatory pumps without the complications associated with traditional drive lines. This innovation addresses the critical challenge of infections related to external power connections, thereby enhancing the viability of Ventricular Assist Devices (VAD) for patients who require long-term support due to advanced heart failure. With an estimated 30,000 to 60,000 heart failure patients in the United States being potential candidates for such devices, Leviticus Cardio's technology represents a significant advancement in medical care for those facing severe heart conditions.
Replidyne is a specialty pharmaceutical company dedicated to the development and commercialization of innovative anti-infective products. The company focuses on creating bio-pharmaceutical solutions that address complex issues in skin care treatment, including oral community antibiotics and interventional treatment systems. Replidyne's development pipeline leverages proprietary DNA replication technology, along with in-licensing efforts, to enhance its offerings. Through its diverse range of products, the company aims to provide effective treatments for patients and medical professionals dealing with skin wounds and related conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.